← Evidence map

ReviewFrontiers in immunology2026

Atorvastatin as a pleiotropic anticancer agent: mechanisms, evidence, and therapeutic repurposing potential.

Jiaqi Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 42112329